Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multinational, Multicentre, Open-label, Randomised, Non-inferiority Trial to Compare Safety and Effectiveness of Meril's Myval Transcatheter Heart Valve (THV) Series vs. Contemporary Valves (Edwards's Sapien THV Series and Medtronic's Evolut THV Series) in Patients With Severe Symptomatic Native Aortic Valve Stenosis

NCT04275726 is registered in ClinicalTrials.gov with Meril Life Sciences Pvt. Ltd. as lead sponsor.

NCT NCT04275726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04275726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multinational, Multicentre, Open-label, Randomised, Non-inferiority Trial to Compare Safety and Effectiveness of Meril's Myval Transcatheter Heart Valve (THV) Series vs. Contemporary Valves (Edwards's Sapien THV Series and Medtronic's Evolut THV Series) in Patients With Severe Symptomatic Native Aortic Valve Stenosis
Lead sponsor
Meril Life Sciences Pvt. Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
November 4, 2020
Completion date
December 31, 2033
Enrollment
988 (estimated)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis